Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema.
Identifieur interne : 002806 ( PubMed/Checkpoint ); précédent : 002805; suivant : 002807Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema.
Auteurs : Janice N. Cormier [États-Unis] ; Robert L. Askew ; Kristi S. Mungovan ; Yan Xing ; Merrick I. Ross ; Jane M. ArmerSource :
- Cancer [ 0008-543X ] ; 2010.
Descripteurs français
- KwdFr :
- MESH :
- diagnostic : Lymphoedème.
- épidémiologie : Lymphoedème.
- étiologie : Lymphoedème.
- Complications postopératoires, Contrôle de qualité, Facteurs de risque, Femelle, Humains, Lymphadénectomie, Tumeurs, Tumeurs du sein.
English descriptors
- KwdEn :
- MESH :
- complications : Breast Neoplasms, Neoplasms.
- diagnosis : Lymphedema.
- epidemiology : Lymphedema.
- etiology : Lymphedema.
- therapy : Breast Neoplasms.
- Female, Humans, Lymph Node Excision, Postoperative Complications, Quality Control, Risk Factors.
Abstract
Secondary lymphedema is a debilitating, chronic, progressive condition that commonly occurs after the treatment of breast cancer. The purpose of the current study was to perform a systematic review and meta-analysis of the oncology-related literature excluding breast cancer to derive estimates of lymphedema incidence and to identify potential risk factors among various malignancies.
DOI: 10.1002/cncr.25458
PubMed: 20665892
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:20665892Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema.</title><author><name sortKey="Cormier, Janice N" sort="Cormier, Janice N" uniqKey="Cormier J" first="Janice N" last="Cormier">Janice N. Cormier</name><affiliation wicri:level="2"><nlm:affiliation>Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. jcormier@mdanderson.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Askew, Robert L" sort="Askew, Robert L" uniqKey="Askew R" first="Robert L" last="Askew">Robert L. Askew</name></author><author><name sortKey="Mungovan, Kristi S" sort="Mungovan, Kristi S" uniqKey="Mungovan K" first="Kristi S" last="Mungovan">Kristi S. Mungovan</name></author><author><name sortKey="Xing, Yan" sort="Xing, Yan" uniqKey="Xing Y" first="Yan" last="Xing">Yan Xing</name></author><author><name sortKey="Ross, Merrick I" sort="Ross, Merrick I" uniqKey="Ross M" first="Merrick I" last="Ross">Merrick I. Ross</name></author><author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:20665892</idno><idno type="pmid">20665892</idno><idno type="doi">10.1002/cncr.25458</idno><idno type="wicri:Area/PubMed/Corpus">002974</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002974</idno><idno type="wicri:Area/PubMed/Curation">002974</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002974</idno><idno type="wicri:Area/PubMed/Checkpoint">002974</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002974</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema.</title><author><name sortKey="Cormier, Janice N" sort="Cormier, Janice N" uniqKey="Cormier J" first="Janice N" last="Cormier">Janice N. Cormier</name><affiliation wicri:level="2"><nlm:affiliation>Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. jcormier@mdanderson.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Askew, Robert L" sort="Askew, Robert L" uniqKey="Askew R" first="Robert L" last="Askew">Robert L. Askew</name></author><author><name sortKey="Mungovan, Kristi S" sort="Mungovan, Kristi S" uniqKey="Mungovan K" first="Kristi S" last="Mungovan">Kristi S. Mungovan</name></author><author><name sortKey="Xing, Yan" sort="Xing, Yan" uniqKey="Xing Y" first="Yan" last="Xing">Yan Xing</name></author><author><name sortKey="Ross, Merrick I" sort="Ross, Merrick I" uniqKey="Ross M" first="Merrick I" last="Ross">Merrick I. Ross</name></author><author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name></author></analytic><series><title level="j">Cancer</title><idno type="ISSN">0008-543X</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast Neoplasms (complications)</term><term>Breast Neoplasms (therapy)</term><term>Female</term><term>Humans</term><term>Lymph Node Excision</term><term>Lymphedema (diagnosis)</term><term>Lymphedema (epidemiology)</term><term>Lymphedema (etiology)</term><term>Neoplasms (complications)</term><term>Postoperative Complications</term><term>Quality Control</term><term>Risk Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Complications postopératoires</term><term>Contrôle de qualité</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie</term><term>Lymphoedème (diagnostic)</term><term>Lymphoedème (épidémiologie)</term><term>Lymphoedème (étiologie)</term><term>Tumeurs ()</term><term>Tumeurs du sein ()</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Lymph Node Excision</term><term>Postoperative Complications</term><term>Quality Control</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Complications postopératoires</term><term>Contrôle de qualité</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie</term><term>Tumeurs</term><term>Tumeurs du sein</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Secondary lymphedema is a debilitating, chronic, progressive condition that commonly occurs after the treatment of breast cancer. The purpose of the current study was to perform a systematic review and meta-analysis of the oncology-related literature excluding breast cancer to derive estimates of lymphedema incidence and to identify potential risk factors among various malignancies.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20665892</PMID><DateCreated><Year>2010</Year><Month>11</Month><Day>08</Day></DateCreated><DateCompleted><Year>2011</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2010</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0008-543X</ISSN><JournalIssue CitedMedium="Print"><Volume>116</Volume><Issue>22</Issue><PubDate><Year>2010</Year><Month>Nov</Month><Day>15</Day></PubDate></JournalIssue><Title>Cancer</Title><ISOAbbreviation>Cancer</ISOAbbreviation></Journal><ArticleTitle>Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema.</ArticleTitle><Pagination><MedlinePgn>5138-49</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cncr.25458</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Secondary lymphedema is a debilitating, chronic, progressive condition that commonly occurs after the treatment of breast cancer. The purpose of the current study was to perform a systematic review and meta-analysis of the oncology-related literature excluding breast cancer to derive estimates of lymphedema incidence and to identify potential risk factors among various malignancies.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The authors systematically reviewed 3 major medical indices (MEDLINE, Cochrane Library databases, and Scopus) to identify studies (1972-2008) that included a prospective assessment of lymphedema after cancer treatment. Studies were categorized according to malignancy, and data included treatment, complications, lymphedema measurement criteria, lymphedema incidence, and follow-up interval. A quality assessment of individual studies was performed using established criteria for systematic reviews. Bayesian meta-analytic techniques were applied to derive summary estimates when sufficient data were available.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 47 studies (7779 cancer survivors) met inclusion criteria: melanoma (n = 15), gynecologic malignancies (n = 22), genitourinary cancers (n = 8), head/neck cancers (n = 1), and sarcomas (n = 1). The overall incidence of lymphedema was 15.5% and varied by malignancy (P < .001): melanoma, 16% (upper extremity, 5%; lower extremity, 28%); gynecologic, 20%; genitourinary, 10%; head/neck, 4%; and sarcoma, 30%. Increased lymphedema risk was also noted for patients undergoing pelvic dissections (22%) and radiation therapy (31%). Objective measurement methods and longer follow-up were both associated with increased lymphedema incidence.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Lymphedema is a common condition affecting cancer survivors with various malignancies. The incidence of lymphedema is related to the type and extent of treatment, anatomic location, heterogeneity of assessment methods, and length of follow-up.</AbstractText><CopyrightInformation>Copyright © 2010 American Cancer Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cormier</LastName><ForeName>Janice N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. jcormier@mdanderson.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Askew</LastName><ForeName>Robert L</ForeName><Initials>RL</Initials></Author><Author ValidYN="Y"><LastName>Mungovan</LastName><ForeName>Kristi S</ForeName><Initials>KS</Initials></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Yan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Merrick I</ForeName><Initials>MI</Initials></Author><Author ValidYN="Y"><LastName>Armer</LastName><ForeName>Jane M</ForeName><Initials>JM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer</MedlineTA><NlmUniqueID>0374236</NlmUniqueID><ISSNLinking>0008-543X</ISSNLinking></MedlineJournalInfo><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011786" MajorTopicYN="N">Quality Control</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20665892</ArticleId><ArticleId IdType="doi">10.1002/cncr.25458</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Texas</li></region></list><tree><noCountry><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name><name sortKey="Askew, Robert L" sort="Askew, Robert L" uniqKey="Askew R" first="Robert L" last="Askew">Robert L. Askew</name><name sortKey="Mungovan, Kristi S" sort="Mungovan, Kristi S" uniqKey="Mungovan K" first="Kristi S" last="Mungovan">Kristi S. Mungovan</name><name sortKey="Ross, Merrick I" sort="Ross, Merrick I" uniqKey="Ross M" first="Merrick I" last="Ross">Merrick I. Ross</name><name sortKey="Xing, Yan" sort="Xing, Yan" uniqKey="Xing Y" first="Yan" last="Xing">Yan Xing</name></noCountry><country name="États-Unis"><region name="Texas"><name sortKey="Cormier, Janice N" sort="Cormier, Janice N" uniqKey="Cormier J" first="Janice N" last="Cormier">Janice N. Cormier</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002806 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002806 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:20665892
|texte= Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:20665892" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |